ArticlePloS one2015

Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.

Petra Leidinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.